Literature DB >> 18230644

Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies.

Karsten Bruins Slot1, Eivind Berge, Paul Dorman, Steff Lewis, Martin Dennis, Peter Sandercock.   

Abstract

OBJECTIVE: To estimate the impact on long term survival of functional status at six months after ischaemic stroke.
DESIGN: Prospective cohort study. Settings Three cohorts: Oxfordshire community stroke project, Lothian stroke register, and the first international stroke trial (in the United Kingdom). PARTICIPANTS: 7710 patients with ischaemic stroke registered between 1981 and 2000 and followed up for a maximum of 19 years. MAIN OUTCOME MEASURES: Functional status at six months after stroke assessed with modified Rankin scale or "two simple questions." Mortality during follow-up. Survival analysis with Kaplan-Meier curves, log rank test, and Cox's regression model.
RESULTS: In a combined analysis of all three cohorts, among patients who survived to assessment six months after the index stroke, the subsequent median length of survival among those independent in daily living and those dependent was 9.7 years (95% confidence interval 8.9 to 10.6) and 6.0 years (5.7 to 6.4), respectively. In a combined analysis of the Oxfordshire and Lothian cohorts, subsequent median survival fell progressively from 12.9 years (10.0 to 15.9) for patients with a Rankin score of 0-1 at six months after the stroke to 2.5 years (1.4 to 3.5) for patients with a Rankin score of 5. All previously stated differences in median survival were significant (log rank test P<0.001). The influence of functional outcome on survival remained significant (P<0.05) in each cohort after adjustment for relevant covariates (such as age, presence of atrial fibrillation, visible infarct on computed tomography, subtype of stroke) in a Cox's regression model.
CONCLUSION: Functional status six months after an ischaemic stroke is associated with long term survival. Early interventions that reduce dependency at six months might have positive effects on long term survival.

Entities:  

Mesh:

Year:  2008        PMID: 18230644      PMCID: PMC2244762          DOI: 10.1136/bmj.39456.688333.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  26 in total

1.  Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview.

Authors:  J T Lindsay Wilson; Asha Hareendran; Anne Hendry; Jan Potter; Ian Bone; Keith W Muir
Journal:  Stroke       Date:  2005-02-17       Impact factor: 7.914

2.  The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation.

Authors:  S Gerzeli; R Tarricone; P Zolo; I Colangelo; M R Busca; C Gandolfo
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

3.  Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke.

Authors:  G P Samsa; R A Reutter; G Parmigiani; M Ancukiewicz; P Abrahamse; J Lipscomb; D B Matchar
Journal:  J Clin Epidemiol       Date:  1999-03       Impact factor: 6.437

4.  Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.

Authors:  Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

5.  High stroke incidence in the prospective community-based L'Aquila registry (1994-1998). First year's results.

Authors:  A Carolei; C Marini; M Di Napoli; G Di Gianfilippo; P Santalucia; M Baldassarre; G De Matteis; F di Orio
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

6.  Trends in the incidence, severity, and short-term outcome of stroke in perth, Western Australia.

Authors:  K Jamrozik; R J Broadhurst; N Lai; G J Hankey; P W Burvill; C S Anderson
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

7.  Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project.

Authors:  Antonio Di Carlo; Maria Lamassa; Marzia Baldereschi; Giovanni Pracucci; Domenico Consoli; Charles D A Wolfe; Maurice Giroud; Anthony Rudd; Ilse Burger; Augusto Ghetti; Domenico Inzitari
Journal:  J Neurol Sci       Date:  2006-03-10       Impact factor: 3.181

8.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

9.  Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

Authors:  H S Jørgensen; H Nakayama; J Reith; H O Raaschou; T S Olsen
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

10.  Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate.

Authors:  H Ellekjaer; J Holmen; B Indredavik; A Terent
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

View more
  53 in total

1.  The prognostic factors that influence long-term survival in acute large cerebral infarction.

Authors:  Sung Yun Cho; Chang Wan Oh; Hee-Joon Bae; Moon-Ku Han; Hyun Park; Jae Seung Bang
Journal:  J Korean Neurosurg Soc       Date:  2011-02-28

2.  Stroke: Measuring disease-free life after thrombolysis.

Authors:  Susan C Fagan
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

3.  Functional status and long term outcome of stroke.

Authors:  Helen Rodgers; Richard Thomson
Journal:  BMJ       Date:  2008-01-29

Review 4.  Causes of death among persons who survive an acute ischemic stroke.

Authors:  Shuai Zhang; Wen-Bin He; Nai-Hong Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

5.  Neopterin as a Predictor of Functional Outcome and Mortality in Chinese Patients with Acute Ischemic Stroke.

Authors:  Xianwei Zeng; Guoqing Zhang; Bin Yang; Bo Zhang; Linpeng Zhang; Ying Ni; Chen Liu; Yumeng Luo
Journal:  Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.590

6.  Comment on the European guidelines for the management of atrial fibrillation.

Authors:  Samir M Said; Ruediger C Braun-Dullaeus
Journal:  Clin Res Cardiol       Date:  2011-01-11       Impact factor: 5.460

7.  Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis.

Authors:  Keun-Sik Hong; Jeffrey L Saver; Dong-Wha Kang; Hee-Joon Bae; Kyung-Ho Yu; Jaseong Koo; Moon-Ku Han; Yong-Jin Cho; Jong-Moo Park; Byung-Chul Lee
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

8.  Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Authors:  Michelle H Leppert; Sharon N Poisson; John D Carroll; David E Thaler; Chong H Kim; Karen D Orjuela; P Michael Ho; James F Burke; Jonathan D Campbell
Journal:  Stroke       Date:  2018-05-02       Impact factor: 7.914

9.  Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.

Authors:  Daniel A Steinhaus; Peter J Zimetbaum; Rod S Passman; Peter Leong-Sit; Matthew R Reynolds
Journal:  J Cardiovasc Electrophysiol       Date:  2016-10-04

10.  A case report exploring activity intensity in inpatient rehabilitation after stroke.

Authors:  Kathryn Zalewski; Julie Kerk; Kristina Laundre; Amber Wacek; Melissa Wiedmeyer
Journal:  Case Rep Med       Date:  2010-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.